• 1
    Bandera EV, Freudenheim JL, Vena JE. Alcohol consumption and lung cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev. 2001; 10: 813821.
  • 2
    Glade MJ. Food, Nutrition and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research. Nutrition. 1999; 6: 523526.
  • 3
    Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer. 2001; 85: 17001705.
  • 4
    International Agency for Research on Cancer. Allyl compounds, aldehyde, epoxies and peroxidies. IARC Monogr Eval Carcinog Risks Hum. 1985; 36: 101132.
  • 5
    Delanco VL. A mutagenicity assessment of acetaldehyde. Mutat Res. 1998; 195: 120.
  • 6
    Helander A, Lindahl-Keissling K. Increased frequency of acetaldehyde-induced sister chromatic exchanges in human lymphocytes treated with an aldehyde dehydrogenase inhibitor. Mutat Res. 1991; 264: 103107.
  • 7
    Woutersen RA, Applman LM, Van Garderen-Hoetmer A, Feron VJ. Inhalation toxicity of acetaldehyde in rat. III. Carcinogenicity study. Toxicology. 1986; 41: 213231.
  • 8
    Feron VJ, Kruysse A, Woutersen RA. Respiratory tract tumors in hamsters exposed to acetaldehyde vapour alone or simultaneously to benzo[a]pyrene or diethylnitrosamine. Eur J Cancer Clin Oncol. 1982; 18: 1331.
  • 9
    Kunitoh S, Imaoka S, Hiroi T, Yabusaki Y, Monna T, Funae Y. Acetaldehyde as well as ethanol is metabolized by human CYP2E1. Pharmacol Exp Ther. 1997; 280: 527532.
  • 10
    Liber CS, DeCarli LM. Hepatic microsomal ethanol oxidizing system. J Biol Chem. 1970; 254: 25052512.
  • 11
    Bosron WF, Li TK. Genetic polymorphisms of human liver alcohol and aldehyde dehydrogenases and their relationship to alcohol metabolism and alcoholism. Hepatology. 1986; 6: 502510.
  • 12
    Harada S, Misawa S, Agarwal DP, Goedde HW. Liver alcohol dehydrogenase and aldehyde dehydrogenase in Japanese: isozyme variation and its possible role in alcohol intoxication. Am J Hum Genet. 1980; 32: 815.
  • 13
    Sun F, Tsuritani I, Yamada Y. Contribution of genetic polymorphisms in ethanol-metabolizing enzymes to problem drinking behavior in middle-aged Japanese men. Behav Genet. 2002; 32: 229236.
  • 14
    Iwahashi K, Miyatake R, Suwaki H, et al. Blood ethanol levels and the CYP2E1 C2 allele. Arukoru Kenkyuto Yakubutsu Ison. 1994; 29: 190194.
  • 15
    Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphism in 5′-flanking region change transcriptional regulation of the human cytochrome P-450IIE1 gene. J Biochem. 1991; 110: 559565.
  • 16
    Coutelle C, Ward PJ, Fleury B, et al. Laryngeal and oropharyngeal cancer and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms. Hum Genet. 1997; 99: 319325.
  • 17
    Harty LC, Caporaso NE, Hayes RB, et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst. 1997; 89: 16981705.
  • 18
    Yokoyama A, Muramatsu T, Ohmori T, Higuchi S, Hayashida M, Ishii H. Esophageal cancer and aldehyde dehydrogenase-2 genotype in Japanese males. Cancer Epidemiol Biomarkers Prev. 1996; 5: 99102.
  • 19
    Hori H, Kawano T, Endo M, Yuasa Y. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. J Clin Gastroenterol. 1997; 25: 568575.
  • 20
    Yokoyama A, Muramatsu T, Ohmori T, et al. Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis. 1998; 19: 13831387.
  • 21
    Nomura T, Noda H, Shibahara T, Yokoyama A, Muramatsu T, Ohmori T. Aldehyde dehydrogenase 2 and glutathione S-transferase M1 polymorphism in relation to the risk for oral cancer in Japanese drinkers. Oral Oncol. 2000; 36: 4246.
  • 22
    Freudenhein JL, Ram M, Nie J, et al. Lung cancer in humans is not associated with lifetime total alcohol consumption or with genetic variation in alcohol dehydrogenase 3 (ADH3)1,2. J Nutr. 2003; 133: 36193624.
  • 23
    Kato S, Shields PG, Caporaso NE, et al. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res. 1992; 52: 67126715.
  • 24
    El-Zein RA, Zwischenberger JB, Abdel-Rahman SZ, Sankar AB, Au WW. Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma. Cancer Lett. 1997; 112: 7178.
  • 25
    Wu X, Shi H, Jiang H, et al. Association between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis. 1997; 18: 967973.
  • 26
    Persson I, Johansson I, Bergling H, et al. Genetic polymorphism of cytochrome P450 2E1 in a Swedish population: relationship to the incidence of lung cancer. FEBS Lett. 1993; 319: 207211.
  • 27
    Marchand LL, Sivaraman L, Pierce L, et al. Association of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggests cell type specificities to tobacco carcinogens. Cancer Res. 1998; 68: 48584863.
  • 28
    Watanabe J, Yang JP, Eguchi H, et al. An RsaI polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. Jpn J Cancer Res. 1995; 86: 245248.
  • 29
    Yamamoto K, Ueno Y, Mizoi Y, Tatsuno Y. Genetic polymorphism of alcohol and aldehyde dehydrogenase and the effects on alcohol metabolism. Arukoru Kenkyuto Yakubutu Ison. 1993; 28: 325.
  • 30
    Muto M, Nakane M, Hitomi Y, et al. Association between aldehyde dehydrogenase gene polymorphisms and the phenomenon of field cancerization in patients with head and neck cancer. Carcinogenesis. 2002; 23: 17591765.
  • 31
    Jones AW. Measuring and reporting the concentration of acetaldehyde in human breath. Alcohol Alcohol. 1995; 30: 271285.
  • 32
    Bouchardy C, Hirvonen A, Coutelle C, Ward PJ, Dayer P, Benhamou S. Role of alcohol dehydrogenase 3 and cytochrome P4502E1genotypes in susceptibility to cancers of upper aerodigestive tract. Int J Cancer. 2000; 87: 734740.
  • 33
    Olshan AF, Weissler MC, Watson MA, Bell DA. Risk of head and neck cancer and the alcohol dehydrogenase-3 genotype. Carcinogenesis. 2001; 22: 5761.
  • 34
    Sturgis EM, Dahlstrom KR, Guan Y, et al. Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx. Cancer Epidemiol Biomarkers Prev. 2001; 10: 273275.
  • 35
    Hung HC, Chuang J, Chien YC, et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev. 1997; 6: 901905.
  • 36
    Hildesheim A, Anderson LM, Chen CJ, et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst. 1997; 89: 12071212.
  • 37
    Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, Kadlubar FF. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P4502E1. Cancer Epidemiol Biomarkers Prev. 1998; 7: 10131018.
  • 38
    Katoh T, Kaneko S, Kohshi K, et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer. 1999; 83: 606609.
  • 39
    Watanabe J, Hayashi S, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanling region. J Biochem. 1994; 116: 321326.
  • 40
    Carriere V, Berthou F, Baird S, Belloe C, Beaune P, de Waziers I. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics. 1996; 6: 203211.
  • 41
    Kim RB, O'Shea D, Wilkinson GR. Intraindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin Phermacol Ther. 1995; 57: 645655.
  • 42
    Kim RB, Yamazaki H, Chiba K, et al. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J Pharmacol Exp Ther. 1996; 279: 411.